Skip to main content

The Lancet Diabetes & Endocrinology

  • ISSN: 2213-8587

Next planned ship date: April 23, 2024

  • 5 Year impact factor: 38.8
  • Impact factor: 44.5

The Lancet Diabetes & Endocrinology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, expl… Read more

Subscription options

Next planned ship date:
April 23, 2024

Institutional subscription on ScienceDirect

Request a sales quote


The Lancet Diabetes & Endocrinology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in diabetes and endocrinology and delivers expert review and candid commentary, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these fields globally.

The Lancet Diabetes & Endocrinology publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.